Phlexglobal, the leading support contract research organization for TMF and eTMF management, has today announced its expansion across the United States with the opening of an office in Philadelphia, Pennsylvania.

Phlexglobal's expansion across the US follows the success enjoyed by the organization's California office which has seen exponential demand for its services across the North American territory. 

The opening of the Philadelphia office comes hot on the heels of April's management buy out (MBO) of the company by UK private equity firm Inflexion, which will allow Phlexglobal to further expand its provision of clinical trial support, underpinned by the recent launch of version 3 of the company's eTMF solution, PhlexEview.

The new East Coast office, which will deliver all Phlexglobal's TMF services including the innovative PhlexEview eTMF solution, will initially employ 20 staff, growing to 50 employees within the first year of operation.

In addition to providing a base for Phlexglobal's resource solutions and operations task force, the 800 square metre office will also house a new records centre, securely storing live TMF documents for Phlexglobal clients across the United States.

Stella Donoghue, Phlexglobal managing director, said: "The launch of a second office only a year after arriving in the US signals how rapidly Phlexglobal has established itself as a major player in the North American market.  

"This is an exciting time for Phlexglobal - the launch of a second US office coupled with the recent MBO will provide a valuable platform for the company to move into new markets including Asia-Pacific, while still maintaining a strong presence in the UK and North America."

Phlexglobal is a specialist global CRO which delivers unique clinical research support solutions to meet its clients' needs through its five core services of resourcing, task force, clinical support services, eTMF & document solutions and training. It works across the pharmaceutical, biotechnology, medical device, CRO and healthcare industries and counts 17 of the top 20 global pharmaceutical companies amongst its clients. 

For more information on Phlexglobal's range of services visit www.phlexglobal.com